Immediate Impact
23 by Nobel laureates 12 from Science/Nature 63 standout
Citing Papers
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid
2023 Standout
Zwitterionic Biomaterials
2022 Standout
Works of Andrew Eisenberger being referenced
One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis
2019
Doxorubicin, Cardiac Risk Factors, and Cardiac Toxicity in Elderly Patients With Diffuse B-Cell Non-Hodgkin's Lymphoma
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Andrew Eisenberger | 295 | 92 | 139 | 323 | 282 | 50 | 1.1k | |
| William R. Friedenberg | 139 | 358 | 144 | 227 | 343 | 34 | 1.0k | |
| Ali A. Youssef | 377 | 32 | 38 | 345 | 100 | 63 | 1.1k | |
| Patrick Ffrench | 209 | 382 | 180 | 133 | 64 | 51 | 1.2k | |
| Kenneth Rosenfield | 479 | 30 | 145 | 560 | 95 | 39 | 1.3k | |
| Kefeng Wang | 98 | 34 | 91 | 230 | 298 | 40 | 867 | |
| Maria M. Aleman | 207 | 495 | 361 | 321 | 80 | 28 | 1.4k | |
| John J. Stuart | 104 | 265 | 62 | 156 | 457 | 51 | 1.3k | |
| Susan S. Smyth | 234 | 361 | 154 | 252 | 70 | 47 | 1.1k | |
| Carlo Giansante | 322 | 88 | 104 | 411 | 133 | 54 | 1.2k | |
| Maria‐Rosa Ghigna | 347 | 13 | 98 | 150 | 313 | 71 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...